Literature DB >> 14760686

High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain.

Christina Chen1, Brad Snedecor, Julie C Nishihara, John C Joly, Nancy McFarland, Dana C Andersen, John E Battersby, Kathleen M Champion.   

Abstract

During production of a humanized antibody fragment secreted into the periplasm of Escherichia coli, proteolytic degradation of the light chain was observed. In order to determine which protease(s) were responsible for this degradation, we compared expression of the F(ab')(2) antibody fragment in several E. coli strains carrying mutations in genes encoding periplasmic proteases. Analysis of strains cultured in high cell density fermentations showed that the combination of mutations in degP prc spr was necessary for the cells to produce high levels of the desired recombinant antibody fragment. In order to eliminate the possible effects of mutations in other genes, we constructed E. coli strains with protease mutations in isogenic backgrounds and repeated the studies in high cell density fermentations. Extensive light chain proteolysis persisted in degP strains. However, light chain proteolysis was substantially decreased in prc and prc spr strains, and was further decreased with the introduction of a degP mutation in prc and prc spr mutant strains. These results show that the periplasmic protease Prc (Tsp) is primarily responsible for proteolytic degradation of the light chain during expression of a recombinant antibody fragment in E. coli, and that DegP (HtrA) makes a minor contribution to this degradation as well. The results also show that spr, a suppressor of growth defects in prc strains, is required for a prc mutant to survive throughout high cell density fermentations. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14760686     DOI: 10.1002/bit.20014

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  18 in total

1.  Selective and efficient extraction of recombinant proteins from the periplasm of Escherichia coli using low concentrations of chemicals.

Authors:  Reza Jalalirad
Journal:  J Ind Microbiol Biotechnol       Date:  2013-07-18       Impact factor: 3.346

2.  Proteomic profiling of recombinant Escherichia coli in high-cell-density fermentations for improved production of an antibody fragment biopharmaceutical.

Authors:  Ilana S Aldor; Denise C Krawitz; William Forrest; Christina Chen; Julie C Nishihara; John C Joly; Kathleen M Champion
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

Review 3.  Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules.

Authors:  Sarah A Wilson; Susan C Roberts
Journal:  Plant Biotechnol J       Date:  2011-11-08       Impact factor: 9.803

4.  Functional expression of a single-chain antibody fragment against human epidermal growth factor receptor 2 (HER2) in Escherichia coli.

Authors:  Vajihe Akbari; Hamid Mir Mohammad Sadeghi; Abbas Jafrian-Dehkordi; Daryoush Abedi; C Perry Chou
Journal:  J Ind Microbiol Biotechnol       Date:  2014-03-27       Impact factor: 3.346

Review 5.  Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.

Authors:  Chung-Jr Huang; Henry Lin; Xiaoming Yang
Journal:  J Ind Microbiol Biotechnol       Date:  2012-01-18       Impact factor: 3.346

Review 6.  With or without sugar? (A)glycosylation of therapeutic antibodies.

Authors:  Dmitrij Hristodorov; Rainer Fischer; Lars Linden
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

7.  Quality control of inclusion bodies in Escherichia coli.

Authors:  Britta Jürgen; Antje Breitenstein; Vlada Urlacher; Knut Büttner; Hongying Lin; Michael Hecker; Thomas Schweder; Peter Neubauer
Journal:  Microb Cell Fact       Date:  2010-05-28       Impact factor: 5.328

8.  Co-evolution of multipartite interactions between an extended tmRNA tag and a robust Lon protease in Mycoplasma.

Authors:  Zhiyun Ge; A Wali Karzai
Journal:  Mol Microbiol       Date:  2009-11-13       Impact factor: 3.501

9.  Optimization of a single-chain antibody fragment overexpression in Escherichia coli using response surface methodology.

Authors:  V Akbari; H Mir Mohammad Sadeghi; A Jafarian-Dehkordi; C Perry Chou; D Abedi
Journal:  Res Pharm Sci       Date:  2015 Jan-Feb

10.  Production of single chain Fab (scFab) fragments in Bacillus megaterium.

Authors:  Eva Jordan; Laila Al-Halabi; Thomas Schirrmann; Michael Hust; Stefan Dübel
Journal:  Microb Cell Fact       Date:  2007-11-27       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.